Dr. Dan Selchen discusses new insights into early diagnosis of MS and assessing a patient’s long-term prognosis while at ECTRIMS 2015 in Barcelona, Spain.
This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.
Dr. Dan Selchen discusses new insights into early diagnosis of MS and assessing a patient’s long-term prognosis while at ECTRIMS 2015 in Barcelona, Spain.
This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.